Finke Daniel P's Form 4 filing
CVS Health Corp (CVS) · filed Aug 5, 2022
- Accession no.
- 0001127602-22-020590
- Filed
- Aug 5, 2022
- Trade date
- Aug 3, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $954.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Finke Daniel PCIK 0001844305 | Officer (EVP/Pres, Health Care Benefits) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2022 | Common Stock | MOption exerciseAcquired | +9,546 | $52.37 | +$499,924.02 | 41,695.96 | Direct | |
| Aug 3, 2022 | Common Stock | SSaleDisposed | −9,546 | $100.00 | −$954,600 | 32,149.96 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2022 | Common Stock | MOption exerciseDisposed | −9,546 | $0.00 | $0 | 19,094 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.